Filing Details
- Accession Number:
- 0001453687-22-000031
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-01-07 16:17:48
- Reporting Period:
- 2022-01-05
- Accepted Time:
- 2022-01-07 16:17:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1453687 | Selecta Biosciences Inc | SELB | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1760229 | Carsten Brunn | C/O Selecta Biosciences, Inc. 65 Grove Street Watertown MA 02472 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-01-05 | 13,597 | $3.09 | 517,958 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.
- The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $2.99 to $3.17. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
